CG Oncology, Inc. ( ($CGON) ) has released its Q3 earnings. Here is a breakdown of the information CG Oncology, Inc. presented to its investors.

Cancer surgery among patients older than 65 years is complex with high morbidity underscoring the need for specialized care at high-quality hospitals.

The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer ...

Bladder cancer is the ninth most common cancer in the world, the fourth most common cancer in men, and the 11th most common ...

The key takeaway is that adjuvant pelvic radiotherapy after surgery can substantially improve pelvic control without causing ...